7-141973235-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_176817.5(TAS2R38):c.455G>A(p.Cys152Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_176817.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R38 | NM_176817.5 | c.455G>A | p.Cys152Tyr | missense_variant | 1/1 | ENST00000547270.1 | NP_789787.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R38 | ENST00000547270.1 | c.455G>A | p.Cys152Tyr | missense_variant | 1/1 | 6 | NM_176817.5 | ENSP00000448219.1 | ||
MGAM | ENST00000465654.5 | c.-3+27238C>T | intron_variant | 3 | ENSP00000419372.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152082Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250496Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135362
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461846Hom.: 0 Cov.: 62 AF XY: 0.00000550 AC XY: 4AN XY: 727216
GnomAD4 genome AF: 0.000164 AC: 25AN: 152082Hom.: 0 Cov.: 31 AF XY: 0.000256 AC XY: 19AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.455G>A (p.C152Y) alteration is located in exon 1 (coding exon 1) of the TAS2R38 gene. This alteration results from a G to A substitution at nucleotide position 455, causing the cysteine (C) at amino acid position 152 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at